Condensed Interim Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Revenue	$ 0	$ 0
Expenses:
Consulting	45,000	0
Research and development	84,203	345,463
Selling, general and administrative (Note 8)	72,777	96,253
Stock-based compensation (Note 7)	36,174	139,648
Total expenses	(238,154)	(581,364)
Interest income	3,095	0
Net loss	(235,059)	(581,364)
Other comprehensive loss
Currency translation differences	(1,159)	(4,022)
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	(1,159)	(4,022)
Total comprehensive loss	$ (236,218)	$ (585,386)
Net loss per share - basic and diluted (in dollars per share)	$ (0)	$ (1)
Weighted-average number of common shares outstanding - basic and diluted (in shares)	91,422,569	91,422,569